Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

T7 phage factor required for managing RpoS in Escherichia coli.

Tabib-Salazar A, Liu B, Barker D, Burchell L, Qimron U, Matthews SJ, Wigneshweraraj S.

Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):E5353-E5362. doi: 10.1073/pnas.1800429115. Epub 2018 May 22.

PMID:
29789383
2.

Exploring the potential of T7 bacteriophage protein Gp2 as a novel inhibitor of mycobacterial RNA polymerase.

du Plessis J, Cloete R, Burchell L, Sarkar P, Warren RM, Christoffels A, Wigneshweraraj S, Sampson SL.

Tuberculosis (Edinb). 2017 Sep;106:82-90. doi: 10.1016/j.tube.2017.07.004. Epub 2017 Jul 18.

PMID:
28802409
3.

Full shut-off of Escherichia coli RNA-polymerase by T7 phage requires a small phage-encoded DNA-binding protein.

Tabib-Salazar A, Liu B, Shadrin A, Burchell L, Wang Z, Wang Z, Goren MG, Yosef I, Qimron U, Severinov K, Matthews SJ, Wigneshweraraj S.

Nucleic Acids Res. 2017 Jul 27;45(13):7697-7707. doi: 10.1093/nar/gkx370.

4.

The Xp10 Bacteriophage Protein P7 Inhibits Transcription by the Major and Major Variant Forms of the Host RNA Polymerase via a Common Mechanism.

Brown DR, Sheppard CM, Burchell L, Matthews S, Wigneshweraraj S.

J Mol Biol. 2016 Oct 9;428(20):3911-3919. doi: 10.1016/j.jmb.2016.08.004. Epub 2016 Aug 8.

5.

Is Meaningful Use the most effective way to build an interoperable health system?

Burchell L.

Health Manag Technol. 2016 Jan-Feb;37(1):14-5. No abstract available.

PMID:
26939516
6.

Adaptation to sustained nitrogen starvation by Escherichia coli requires the eukaryote-like serine/threonine kinase YeaG.

Figueira R, Brown DR, Ferreira D, Eldridge MJ, Burchell L, Pan Z, Helaine S, Wigneshweraraj S.

Sci Rep. 2015 Dec 1;5:17524. doi: 10.1038/srep17524.

7.

Systematic mutational analysis of the LytTR DNA binding domain of Staphylococcus aureus virulence gene transcription factor AgrA.

Nicod SS, Weinzierl RO, Burchell L, Escalera-Maurer A, James EH, Wigneshweraraj S.

Nucleic Acids Res. 2014 Nov 10;42(20):12523-36. doi: 10.1093/nar/gku1015. Epub 2014 Oct 28.

8.

High throughput mutagenesis for identification of residues regulating human prostacyclin (hIP) receptor expression and function.

Bill A, Rosethorne EM, Kent TC, Fawcett L, Burchell L, van Diepen MT, Marelli A, Batalov S, Miraglia L, Orth AP, Renaud NA, Charlton SJ, Gosling M, Gaither LA, Groot-Kormelink PJ.

PLoS One. 2014 Jun 2;9(6):e97973. doi: 10.1371/journal.pone.0097973. eCollection 2014.

9.

A molecular explanation for the recessive nature of parkin-linked Parkinson's disease.

Spratt DE, Martinez-Torres RJ, Noh YJ, Mercier P, Manczyk N, Barber KR, Aguirre JD, Burchell L, Purkiss A, Walden H, Shaw GS.

Nat Commun. 2013;4:1983. doi: 10.1038/ncomms2983.

10.

PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65.

Kondapalli C, Kazlauskaite A, Zhang N, Woodroof HI, Campbell DG, Gourlay R, Burchell L, Walden H, Macartney TJ, Deak M, Knebel A, Alessi DR, Muqit MM.

Open Biol. 2012 May;2(5):120080. doi: 10.1098/rsob.120080.

11.

Small, N-terminal tags activate Parkin E3 ubiquitin ligase activity by disrupting its autoinhibited conformation.

Burchell L, Chaugule VK, Walden H.

PLoS One. 2012;7(4):e34748. doi: 10.1371/journal.pone.0034748. Epub 2012 Apr 4.

12.

Structural basis for the broad specificity to host-cell ligands by the pathogenic fungus Candida albicans.

Salgado PS, Yan R, Taylor JD, Burchell L, Jones R, Hoyer LL, Matthews SJ, Simpson PJ, Cota E.

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15775-9. doi: 10.1073/pnas.1103496108. Epub 2011 Sep 6.

13.

Autoregulation of Parkin activity through its ubiquitin-like domain.

Chaugule VK, Burchell L, Barber KR, Sidhu A, Leslie SJ, Shaw GS, Walden H.

EMBO J. 2011 Jun 21;30(14):2853-67. doi: 10.1038/emboj.2011.204.

14.

The structure of the genomic Bacillus subtilis dUTPase: novel features in the Phe-lid.

García-Nafría J, Burchell L, Takezawa M, Rzechorzek NJ, Fogg MJ, Wilson KS.

Acta Crystallogr D Biol Crystallogr. 2010 Sep;66(Pt 9):953-61. doi: 10.1107/S0907444910026272. Epub 2010 Aug 13.

PMID:
20823546
15.

Stimulus 101. The $19 billion health-care IT giveaway and how your practice can benefit.

Burchell L.

Conn Med. 2009 Apr;73(4):249-51. No abstract available.

PMID:
19413094
16.

Prospective study of factors predicting adherence to medical advice in men with testicular cancer.

Moynihan C, Norman AR, Barbachano Y, Burchell L, Huddart R, Dearnaley DP, Horwich A.

J Clin Oncol. 2009 May 1;27(13):2144-50. doi: 10.1200/JCO.2008.16.1901. Epub 2009 Mar 23.

17.

Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues.

Mosser AG, Vrtis R, Burchell L, Lee WM, Dick CR, Weisshaar E, Bock D, Swenson CA, Cornwell RD, Meyer KC, Jarjour NN, Busse WW, Gern JE.

Am J Respir Crit Care Med. 2005 Mar 15;171(6):645-51. Epub 2004 Dec 10.

PMID:
15591468
18.

Cerebrovascular mortality in patients with pituitary adenoma.

Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B.

Clin Endocrinol (Oxf). 2002 Dec;57(6):713-7.

PMID:
12460319
19.

Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium.

Mosser AG, Brockman-Schneider R, Amineva S, Burchell L, Sedgwick JB, Busse WW, Gern JE.

J Infect Dis. 2002 Mar 15;185(6):734-43. Epub 2002 Feb 19.

PMID:
11920291
20.

Increased glomerular deposits of von Willebrand factor in chronic, but not acute, rejection of primate renal allografts.

Lagoo AS, Buckley PJ, Burchell LJ, Peters D, Fechner JH, Tsuchida M, Dong Y, Hong X, Brunner KG, Oberley TD, Hamawy MM, Knechtle SJ.

Transplantation. 2000 Sep 27;70(6):877-86.

PMID:
11014641
21.

Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.

Jalali R, Brada M, Perks JR, Warrington AP, Traish D, Burchell L, McNair H, Thomas DG, Robinson S, Johnston DG.

Clin Endocrinol (Oxf). 2000 Jun;52(6):695-702.

PMID:
10848873
22.

The incidence of cerebrovascular accidents in patients with pituitary adenoma.

Brada M, Burchell L, Ashley S, Traish D.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):693-8.

PMID:
10524424
23.

Evaluation of adjuvant psychological therapy in patients with testicular cancer: randomised controlled trial.

Moynihan C, Bliss JM, Davidson J, Burchell L, Horwich A.

BMJ. 1998 Feb 7;316(7129):429-35.

Supplemental Content

Loading ...
Support Center